Guardian Pharmacy Services, Inc. (GRDN) stock

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30157% above fair value

$49.38−0.60 (-1.20%)

Close on Nov 12, 2026Market cap $3.13BP/E –Yield –

Guardian Pharmacy Services statistics

73 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 10, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $3.13B; $369.78M
Enterprise Value: $3.02B; $383.70M
PS Ratio: 2.15; 0.56
P/OCF Ratio: 27.42; 10.56

Enterprise valuationIndustry

EV / Sales: 2.07; 0.56
EV / EBITDA: 25.69; 12.09
EV / EBIT: 32.09; 12.89

Share statisticsIndustry

Shares Outstanding: 63M; 41M
Float: 36M; 36M
Shares Held by Insiders: 43.6%; 8.39%
Shares Held by Institutions: 46.6%; 43.9%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: -7.50%; -1.30%
Short % of Float: 6.17%; 7.56%
Short % of Shares Outstanding: 3.48%; 5.07%
Days to Cover: 6.64; 4.89

Stock price statisticsIndustry

52-Week High: $50.59; –
52-Week Low: $26.34; –
20-Day Moving Average: $42.06; –
50-Day Moving Average: $42.29; –
200-Day Moving Average: $38.76; –
Average True Range (14): $2.02; –
Price Change (1 Week): 23.9%; -1.14%
Price Change (1 Month): 21.7%; 2.93%
Price Change (3 Months): 28.5%; -11.2%
Price Change (6 Months): 36.1%; -10.7%
Price Change (YTD): 64.1%; -21.2%
Price Change (1 Year): 58.0%; -14.7%
Average Volume (10 Days): 683,897; –
Average Volume (20 Days): 508,602; –
Average Volume (90 Days): 479,270; –
Relative Volume: 0.81; 0.74
Relative Strength Index (14): 70.6; 51.4
Volatility (1 Year): 43.1%; 64.5%
Beta (5 Years): 0.56; 1.10

MarginsIndustry

Gross Margin: 22.4%; 39.8%
Operating Margin: 6.46%; -0.00%
Pretax Margin: 7.22%; -0.43%
Profit Margin: 5.13%; -0.21%
EBITDA Margin: 8.07%; 1.22%

Returns on capitalIndustry

Return on Assets (ROA): 17.0%; -1.49%
Return on Capital Employed (ROCE): 30.1%; 2.23%

Financial positionIndustry

Current Ratio: 1.65; 1.16
Quick Ratio: 1.27; 0.44
Interest Coverage: 145.28; -0.18

GrowthIndustry

Revenue Growth (YoY): 4.85%; 6.73%
Net Income Growth (YoY): 85.8%; 30.3%

EfficiencyIndustry

Asset Turnover: 3.30; 1.46
Inventory Turnover: 21.54; 5.87
Revenue Per Employee: $404.74K; $404.74K
Profits Per Employee: $20.77K; -$2.22K
Employee Count: 3,600; 445
WACC: 7.66%; 9.18%

Income statement (TTM)Industry

Revenue: $1.46B; $351.39M
Gross Profit: $327.08M; $247.20M
Operating Income: $94.14M; -$128.01K
Pretax Income: $105.16M; -$578.22K
Net Income: $74.77M; -$578.22K
EBITDA: $117.60M; $185.52K

Balance sheetIndustry

Cash & Short-Term Investments: $119.66M; $21.81M
Net Cash (Debt): $119.66M; $10.47K
Net Cash Per Share: $1.89; $0.00
Working Capital: $115.73M; $2.15M

Cash flow (TTM)Industry

Operating Cash Flow: $114.06M; $1.51M

Dividends and yieldsIndustry

Earnings Yield: 2.39%; 2.62%
Buyback Yield: -0.97%; 1.51%
Shareholder Yield: -0.97%; 1.52%

Taxes and interestIndustry

Interest Expense: $648.00K; $1.99M
Income Tax: $29.11M; $1.14M
Effective Tax Rate: 27.7%; 22.2%

Scores and fair valueIndustry

Altman Z-Score: 13.07; 2.09
Piotroski F-Score: 7; 5
Beneish M-Score: -2.95; -2.70

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	GRDN	S&P 500	Difference
1 month	+22.0%	-2.7%	+24.7 pts
3 months	+28.0%	-1.7%	+29.7 pts
Year to date	+64.1%	+11.9%	+52.2 pts
1 year	+56.5%	+12.0%	+44.5 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M GRDN shares were sold short on Oct 30, 2026, down 7.5% from the previous report, or 6.17% of the shares available to trade. At recent volumes it would take 6.6 days to buy them back. Over the last 20 sessions, 61.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,204,814	-7.5%	332,004	6.6
Oct 15, 2026	2,383,673	-3.9%	448,487	5.3
Sep 30, 2026	2,480,634	+2.2%	810,875	3.1
Sep 15, 2026	2,427,722	-20.2%	651,725	3.7
Aug 31, 2026	3,042,463	+1.2%	323,308	9.4
Aug 14, 2026	3,007,632	+5.4%	406,699	7.4
Jul 31, 2026	2,853,089	+2.2%	298,765	9.6
Jul 15, 2026	2,791,798	-9.6%	391,398	7.1
Jun 30, 2026	3,089,948	-4.7%	588,424	5.3
Jun 15, 2026	3,243,688	+11.4%	374,122	8.7
May 29, 2026	2,911,237	+5.2%	395,636	7.4
May 15, 2026	2,766,146	+2.6%	440,561	6.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

Where these numbers come from

Parsed from the XBRL in Guardian Pharmacy Services's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GRDN.

Compare: GRDN vs NHC · GRDN vs PETS · GRDN vs YI · GRDN vs LESLQ · GRDN vs OMCL

Revenue growth4.9% · median -0.0%

Gross margin22.4% · median 33.7%

Operating margin6.5% · median -5.7%

Net margin5.1% · median -6.7%

Company	Revenue	Growth
NHC	$1.58B	+5.6%
GRDN	$1.46B	+4.9%
OMCL	$1.24B	+5.6%
LESLQ	$1.18B	-5.7%
PETS	$160.26M	-19.2%
YI	–	–

Company

Next earnings (est.): Mar 10, 2027, during market hours
Exchange: NYSE
Industry: Retail-Drug Stores and Proprietary Stores
Fiscal year ends: December 31
Employees: 3,600
Held by institutions: 46.6%
Auditor: Ernst & Young LLP
SEC CIK: 1802255

Advertisement
300 × 250

See a number that looks wrong?